1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow B-Cell Acute Lymphoblastic Leukaemia: new trials by email Literature Review of B-Cell Acute Lymphoblastic Leukaemia trials Research Report on B-Cell Acute Lymphoblastic Leukaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL Blinatumomab, Haplo-Mismatched Cell Therapy (HMCT) - B-Cell Acute Lymphoblastic Leukaemia, ALL, Adult | Phase 1 | Completed | Cedars-Sinai Medical Center | 22 | 2020-02-14 | 2025-02-05 |
| CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies CD19 CAR T - B-cell Malignancy, B-cell Lymphoma | Phase 1 | Unknown | Shanghai Tong Ren Hospital | 9 | 2018-04-24 | 2020-11-05 |
Burkitt Lymphoma (2) · Lymphoma, B-Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
DNA Virus Infections (2) · Epstein-Barr Virus Infections (2) · Hemic and Lymphatic Diseases (2) · Herpesviridae Infections (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Tumor Virus Infections (2) · Virus Diseases (2)
blinatumomab (1)
Cedars-Sinai Medical Center (1) · Shanghai Tong Ren Hospital (1)
China (1) · United States (1)
Ligen Liu (1) · Noah Merin, MD PhD (1)